Although N-acetylaspartate (NAA) has long been recognized as the most abundant amino acid in neurons by far, its primary role has remained a mystery. Based on its unique tertiary structure, we explored the potential of NAA to modulate aggregation of amyloid-beta (Aβ) peptide 1-42 via multiple corroborating aggregation assays along with electron microscopy. Thioflavin-T fluorescence assay demonstrated that at physiological concentrations, NAA substantially inhibited the initiation of Aβ fibril formation. In addition, NAA added after 25 min of Aβ aggregation was shown to break up preformed fibrils. Electron microscopy analysis confirmed the absence of mature fibrils following NAA treatment. Furthermore, fluorescence correlation spectroscopy and dynamic light scattering measurements confirmed significant reductions in Aβ fibril hydrodynamic radius following treatment with NAA. These results suggest that physiological levels of NAA could play an important role in controlling Aβ aggregation in vivo where they are both found in the same neuronal compartments.
Introduction
Amongst amino acids in the brain, NAA is second only to glutamate in total concentration (Tsai and Coyle, 1995) . However, while high concentrations of glutamate are found in all compartments of the brain, NAA is predominantly located in axons and the soma, where it is by far the most abundant amino acid, at 12-15 mM (Benedetti et al., 2007; Glodzik et al., 2015) . Although the high concentration of glutamate can easily be attributed to its major dual roles as a building block for protein synthesis and as the most abundant excitatory neurotransmitter (Watkins, 2000) , surprisingly, the primary function of NAA has not been identified. Indeed, roles for NAA characterized thus far appear to represent general repurposing of the abundant amino acid rather than pointing to its essential cellular function. For example, once synthesized from acetate and aspartate in axons, NAA can be transferred to oligodendrocytes, where it is cleaved to release the acetate group to serve as a building block for myelin production (Chakraborty et al., 2001) . However, it is unclear why such a complicated scheme would be specifically employed for building myelin since acetate is a common and easily produced end product in all cells. As such, this pathway may simply reflect a local recycling of NAA and its products to accommodate the high production and turnover in axons, which is essential to maintain a precise NAA concentration. In addition, while NAA has also been shown to act as a neuronal osmolyte helping with fluid balance (Taylor et al., 1994) , similarly, it remains unclear why neurons specifically use NAA rather than many other more common osmolytes (Law, 1994) .
Proton magnetic resonance spectroscopy (MRS) of the brain shows that the very large peak for NAA dominates the water-suppressed spectra, due primarily to its high concentration and unique structure. Since NAA is predominantly found in neuronal compartments and its relative concentration is highly stable under normal physiological conditions, its MRS signature has been established over decades as a reliable biomarker of neuronal integrity (Luyten and den Hollander, 1986; Rigotti et al., 2007) . In neurodegenerative disorders and traumatic brain injury (TBI), regional decreases in NAA concentration are commonly found, particularly in the white matter (Brown et al., 2018; Cheng et al., 2002; Kantarci et al., 2007; Klunk et al., 1992 
